Insight Molecular Diagnostics Reports Q4 2025 Earnings and Strategic Milestones
Published on 3/26/2026
AI Summary
Insight Molecular Diagnostics announced its Q4 2025 earnings results, highlighting strategic milestones achieved during the quarter. The company reported a revenue increase of 15% year-over-year, totaling $10 million for the quarter. Significant developments included the launch of two new diagnostic tests and expansion into three additional markets. These advancements are expected to enhance the company's market position and drive future growth.
